Michelle L. Schoettler, MD
Aflac Cancer & Blood Disorders Center
Children’s Healthcare of Atlanta
Acting Assistant Professor of Pediatrics,
Emory University School of Medicine
Dr. Schoettler grew up in Florida but made her way north throughout her training. She completed medical school at Wake Forest University School of Medicine, residency training at Boston Children’s Hospital, and hematology/oncology/hematopoietic cellular therapy fellowship at Boston Children’s/Dana Farber Cancer and Blood Disorder Center. She was thrilled to join Children’s Healthcare of Atlanta as an Assistant Professor in 2020.
Dr. Schoettler’s clinical interest is hematopoietic cellular therapy (HCT) for hematologic malignancies. Her research focus has been the study of transplant associated thrombotic microangiopathy (TA-TMA), a potentially life-threatening complication of HCT. She has multiple first author publications and presentations at national meetings describing her work. Dr. Schoettler ultimately aims to improve outcomes after HCT and feels privileged to work with children and their families throughout the HCT process.
Outside of work, Dr. Schoettler enjoys spending time with her two sons and her husband exploring restaurants and parks in Atlanta.
Areas of Interest:
Transplant Associated Thrombotic Microangiopathy (TA-TMA)
Veno-occlusive Disease (VOD)
Clinical trials in HCT
Education and Training:
Medical School: Wake Forest University School of Medicine
Residency: Boston Combined Pediatric Residency (Boston Children’s Hospital/Boston Medical Center)
Fellowship: Boston Children’s/Dana Farber Cancer Institute
American Board of Pediatrics
Professional Scientific Societies:
American Society for Transplantation and Cellular Therapy
American Society of Hematology
American Society of Pediatric Hematology and Oncology
Honors and Awards:
Alpha Omega Alpha (AOA), Wake Forest University School of Medicine
Senior Resident Teaching Award, Boston Children’s Hospital, Harvard Medical School